Go Back
Fulgent Genetics, Inc. reports $15.3 million Q1 profit
By USInMinutes - May 05, 2023, 08:16 AM ET
Last Updated - Jul 18, 2023, 03:38 PM EDT
The company generated $66.20 million in quarterly revenue
Fulgent Genetics, Inc. [FLGT] has reported fiscal Q1 profit of $15.30 million.
On a per-share basis, the DE based company said its diluted earnings are $0.52.
The Medical Laboratories firm posted revenue of $66.20 million in this period.
Also Read:
- Fulgent Reports First Quarter 2023 Financial Results
- Fulgent Genetics to Announce First Quarter 2023 Financial Results on Friday May 5, 2023
- CONTINUED INVESTIGATION ALERT REMINDER: Scott+Scott Attorneys at Law LLP Investigates Fulgent ...
- FULGENT ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on ...
- Barrack, Rodos & Bacine (BR&B) Is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News